Distribution for the sensitivity (SEN) (%) and specificity (SPE) (%) for the healthy control (HC), Alzheimer’s disease (AD) and Parkinson’s disease (PD) groups, accuracy (ACC)...

Demographic data of the control and patient groups.

A top priority in biomarker development for Alzheimer’s disease (AD) and Parkinson’s disease (PD) is the focus on early diagnosis, where the use of the retina is a promising...